Literature DB >> 7685317

Immunovascular communication: activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines.

M Schneemann1, G Schoedon, K Frei, A Schaffner.   

Abstract

A murine endothelial cell line, send1, was found to produce substantial amounts of nitric oxide, particularly after activation with cytokines. The endothelial cell activation paralleled that of macrophages. Macrophage deactivation opposing activation has recently been brought into focus. We therefore studied the cytokine-mediated deactivation of endothelial cells in send1 and vascular strips. Our observations document that activation of nitric oxide synthase of endothelial cells can be counterbalanced by deactivating cytokines such as interleukin-4, interleukin-8, interleukin-10 and transforming growth factor-beta. Deactivation of nitric oxide synthase in endothelial cells might be an essential mechanism for the control of immune-mediated vasodilatation or septic shock and represents a novel mechanism of communication between the immune and the vascular systems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685317     DOI: 10.1016/0165-2478(93)90085-g

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

1.  Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide.

Authors:  A Morikawa; N Koide; Y Kato; T Sugiyama; D Chakravortty; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

Authors:  M Perretti; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  Evidence that nitric oxide is an endogenous antiangiogenic mediator.

Authors:  E Pipili-Synetos; E Sakkoula; G Haralabopoulos; P Andriopoulou; P Peristeris; M E Maragoudakis
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

4.  NOS1-, NOS3-, PIK3CA-, and MAPK-pathways in skin following radiation therapy.

Authors:  Steffen Koerdt; Nadine Tanner; Niklas Rommel; Nils H Rohleder; Gesche Frohwitter; Oliver Ristow; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  Biomark Res       Date:  2017-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.